Inventor
CONTORNI MARIO
IT20 patents
⚠️ This page may combine multiple inventors who share the name “CONTORNI MARIO”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
CONTORNI MARIO
9 patentsUS8398988B2Mar 19, 2013
Adjuvanting meningococcal factor H binding protein
CONTORNI MARIO64 citations96
US8765135B2Jul 1, 2014
Liquid vaccines for multiple meningococcal serogroups
CONTORNI MARIO17 citations92
US8802111B2Aug 12, 2014
Manufacture of vaccines that contain both hepatitis B virus surface antigens and surfactant
CONTORNI MARIO7 citations83
US10195264B2Feb 5, 2019
Immunising against meningococcal serogroup Y using proteins
CONTORNI MARIO11 citations81
US8883166B2Nov 11, 2014
Combination vaccines with whole cell pertussis antigen
CONTORNI MARIO9 citations78
US9511132B2Dec 6, 2016
Mixing lyophilised meningococcal vaccines with D-T-Pa vaccines
CONTORNI MARIO5 citations72
US9278126B2Mar 8, 2016
Influenza vaccines with reduced amounts of squalene
CONTORNI MARIO2 citations61
US9259460B2Feb 16, 2016
Combination vaccines with low dose of Hib conjugate
CONTORNI MARIO0 citations51
USRE45587EJun 30, 2015
Vaccines comprising aluminum adjuvants and histidine
CONTORNI MARIO0 citations49
GLAXOSMITHKLINE BIOLOGICALS SA
4 patentsUS10568953B2Feb 25, 2020
Adjuvanting meningococcal factor H binding protein
GLAXOSMITHKLINE BIOLOGICALS SA6 citations83
US10245311B2Apr 2, 2019
Adjuvanting meningococcal factor H binding protein
GLAXOSMITHKLINE BIOLOGICALS SA1 citations72
US12128094B2Oct 29, 2024
Immunogenic compositions comprising OMVs, an acellular pertussis antigen, a tetanus toxoid and a diphtheria toxoid
GLAXOSMITHKLINE BIOLOGICALS SA0 citations56
US9855324B2Jan 2, 2018
Immunogenic compositions
GLAXOSMITHKLINE BIOLOGICALS SA0 citations51